daunorubicin has been researched along with nogalamycin in 97 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 73 (75.26) | 18.7374 |
1990's | 15 (15.46) | 18.2507 |
2000's | 5 (5.15) | 29.6817 |
2010's | 4 (4.12) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lin, CC; Van de Sande, JH | 1 |
Johnston, FP; Jorgenson, KF; Lin, CC; van de Sande, JH | 1 |
Dimmock, NJ; Minor, PD | 1 |
Strauss, DG | 1 |
Ganapathi, R; Krishan, A | 2 |
Bachur, NR; Clawson, RE; Cohen, JL; Egorin, MJ; Ross, LA | 1 |
Johnson, JH; Marshall, VP; Reineke, LM; Reisender, EA; Wiley, PF | 1 |
Bassleer, R; Chévremont, M | 1 |
Marshall, VP; Wiley, PF | 1 |
Besterman, JM; George, JW; Ghate, S; Matson, SW | 1 |
Satoh, H; Taguchi, H; Yahagi, S | 1 |
Matsuo, K; Sugimoto, Y; Takeda, S; Tsukagoshi, S; Yamada, Y | 1 |
Earhart, RH; Maroun, JA; Robillard, L; Stewart, DJ; Verma, S | 1 |
Ahmann, FR; Chapman, R; Crawford, ED; Goodman, P; Lowe, BA; Natale, RB; Spicer, CF; Stephens, RL | 1 |
Matsuo, K; Sugimoto, Y; Takeda, S; Toko, T; Tsukagoshi, S; Wierzba, K; Yamada, Y | 1 |
Atwell, J; Politi, PM; Sinha, BK | 1 |
Gao, YG; Liaw, YC; Robinson, H; Wang, AH | 1 |
Bash, P; Egli, M; Frederick, CA; Qi, G; Rich, A; van Boom, JH; van der Marel, GA; Williams, LD | 1 |
Searle, MS; Wakelin, LP | 1 |
Liaw, YC; Robinson, H; van Boom, JH; van der Marel, GA; Wang, AH | 1 |
Fox, KR; Waring, MJ | 3 |
Fuska, J; Fusková, A; Podojil, M; Prikrylová, V; Sturdíková, M | 1 |
Cole, SP; Gerlach, JH; Mirski, SE | 1 |
Bungo, M; Fujiwara, Y; Fukuda, M; Horichi, N; Minato, K; Nakagawa, K; Niimi, S; Ohe, Y; Saijo, N; Sasaki, Y | 1 |
Cavalli, F; Kaye, SB; Renard, J; Sessa, C; ten Bokkel Huinink, W | 1 |
Phillips, DR; White, RJ | 1 |
Buckner, JC; Edmonson, JH; Ingle, JN; Schaid, DJ | 1 |
Adams, WJ; Brewer, JE; Dalm, EA; Hosley, JD; McGovren, JP | 1 |
Earhart, RH; Maroun, JA; Perrault, D; Stewart, DJ; Verma, S | 1 |
Gao, YG; Liaw, YC; Robinson, H; van Boom, JH; van der Marel, GA; Wang, AH | 1 |
Dombernowsky, P; Hansen, M; Joss, RA; Monfardini, S; Pinedo, HM; Renard, J | 1 |
Cheng, E; Chuang, YJ; Niedzwiecki, D; Sordillo, PP; Sternberg, CN | 1 |
Ganapathi, R; Grabowski, D; Israel, M; Schmidt, H; Seshadri, R | 1 |
Bachur, NR; Dodion, P; Egorin, MJ; Engisch, KL | 1 |
Adams, EG; Bhuyan, BK; Crampton, SL; Johnson, M | 1 |
Aisner, J; Egorin, MJ; Engisch, KL; Forrest, A; Sigman, LM; Van Echo, DA; Whitacre, MY | 1 |
Raymond, V; Young, CW | 1 |
Dorr, FA; Kisner, DL; Kuhn, JG; Schwartz, R; Von Hoff, DD | 1 |
Dodion, P; Kenis, Y; Kitt, MM; Klastersky, J; Rombaut, W; Rozencweig, M; Sanders, C | 1 |
Ratain, MJ; Schilsky, RL | 1 |
Aisner, J; Egorin, MJ; Sigman, LM; Van Echo, DA; Whitacre, MY | 1 |
Adams, EG; Bhuyan, BK | 1 |
Capizzi, RL; Chandrasekaran, B; Dimling, J | 1 |
Clagett-Carr, K; Leyland-Jones, B; Russo, M; Sarosy, G; Weiss, RB | 1 |
Brown, TD; Donehower, RC; Ettinger, DS; Grochow, LB; Rice, AP | 1 |
Long, HJ; Moertel, CG; Powis, G; Schutt, AJ | 1 |
Barrett, J; Benson, AB; Blough, R; Chernicoff, D; Hoeltgen, T; Johnson, C; Kilton, L; Knop, RH; Locker, GY | 1 |
D'Incalci, M; Figoli, F; Monfardini, S; Sorio, R; Tirelli, U; Zadro, D; Zanette, ML | 1 |
Conley, BA; Egorin, MJ; Forrest, A; Sinibaldi, V; Van Echo, DA; Zuhowski, EG | 1 |
Gundersen, S; Monfardini, S; Pinedo, H; Renard, G; Van Glabbeke, M | 1 |
Cheng, EW; Hollander, P; Magill, GB; Sternberg, CN | 1 |
Crespeigne, N; de Valeriola, D; Dodion, P; Joggi, J; Kenis, Y; Peeters, B; Piccart, M; Tueni, E; van Berchem, C; Wery, F | 1 |
Cavalli, F; Gundersen, S; Renard, J; Sessa, C; ten Bokkel Huinink, W | 1 |
Edmonson, JH; Ingle, JN; Long, HJ; Loprinzi, CL; Schaid, DJ; Schutt, AJ | 1 |
Decoster, G; Holdener, EE; Ludwig, C; Pinedo, HM; Renard, G; ten Bokkel Huinink, WW | 1 |
Crespeigne, N; de Valeriola, D; Dodion, P; Joggi, J; Kenis, Y; Peeters, B; van Berchem, C; Wery, F | 1 |
Denny, WA; Hall, JG; Searle, MS; Wakelin, LP | 1 |
Fox, KR | 1 |
Chen, KX; Gresh, N; Trinquier, G | 1 |
Brassett, C; Fox, KR; Waring, MJ | 1 |
Abdella, BR; Fisher, J; McLane, KE | 1 |
Choudhury, K; Neogy, RK; Panda, CK | 1 |
Chakraborty, R; Choudhury, K; Dhar, TC; Neogy, RK | 1 |
Bhuyan, BK; Harbach, PR; Johnson, MA; Mazurek, JH; Shu, VS; Trzos, RJ; Zimmer, DM | 1 |
Adams, WJ; Hamilton, RD; McGovren, JP; Pratt, EA | 1 |
Christopher, JP; Cradock, JC; Lassus, M; McGovren, JP; Nelson, KG; Plowman, J | 1 |
Chowdhury, K; Neogy, RK | 1 |
Bhuyan, BK; Crampton, SL; McGovren, JP | 1 |
Chowdhury, I; Chowdhury, K; Neogy, RK | 1 |
Adams, EG; Bhuyan, BK; Crampton, SL | 1 |
Brown, JE; Brown, JR; Wilkinson, PA | 1 |
Brown, JR; Collier, DA; Neidle, S | 1 |
Chakraborty, B; Chowdhury, K; Ganguli, R; Neogy, RK | 1 |
Biswas, N; Chakraborty, B; Choudhury, K; Neogy, RK | 1 |
Elrod, DW; Houser, DJ; Richard, FA; Wiley, PF | 1 |
Grant, AD; Krueger, WC; Li, LH; Richardson, CL; Schpok, SL | 1 |
Ennis, HL | 1 |
Krueger, WC; Li, LH; McGovren, JP; Merritt, MV; Moscowitz, A; Neta, P; Pschigoda, LM; Schpok, SL | 1 |
Chatterji, H; Deb, JK; Neogy, RK | 1 |
Bhuyan, BK; Blowers, CL; Shugars, KD | 1 |
Bhuyan, BK; Blowers, CL; Crampton, SL; Shugars, KD | 1 |
Falaschi, A; Ochem, A; Phan, TN; Tuteja, N; Tuteja, R | 1 |
Hakala, J; Mäntsälä, P; Skurnik, M; Torkkell, S; Ylihonko, K | 1 |
Phan, TN; Tuteja, N | 1 |
Beck, JL; Kapur, A; Sheil, MM | 1 |
Pham, XH; Tuteja, N | 1 |
Ehtesham, NZ; Phan, TN; Tuteja, N; Tuteja, R | 1 |
Ehtesham, NZ; Nasirudin, KM; Sopory, SK; Tuteja, N; Tuteja, R | 1 |
Brodbelt, JS; Keller, KM; Oehlers, L; Zhang, J | 1 |
Davies, DB; Evstigneev, MP; Khomich, VV | 1 |
Pham, XH; Tran, NQ; Tuteja, N; Tuteja, R | 1 |
Ahmad, M; Tabassum, F; Tarique, M; Tuteja, R | 1 |
Banerjee, S; Banerjee, T; Ghosh, S; Mukhopadhyay, R; Rakshit, T; Sett, S | 1 |
Chauhan, M; Tarique, M; Tuteja, R | 1 |
3 review(s) available for daunorubicin and nogalamycin
Article | Year |
---|---|
Anthracyclines--modern tumour-inhibiting agents.
Topics: Animals; Antibiotics, Antineoplastic; Bacteria; Chemical Phenomena; Chemistry; Daunorubicin; Doxorubicin; Glycosides; Humans; Naphthacenes; Neoplasms; Nogalamycin | 1978 |
Clinical assessment of the structure-activity relationship of anthracyclines and related synthetic derivatives.
Topics: Aclarubicin; Anthraquinones; Antibiotics, Antineoplastic; Breast Neoplasms; Carubicin; Cell Survival; Daunorubicin; Doxorubicin; Drug Evaluation; Epirubicin; Heart; Humans; Idarubicin; Leukemia; Menogaril; Mitoxantrone; Naphthacenes; Nogalamycin; Sarcoma; Structure-Activity Relationship | 1986 |
Anthracycline analogs: the past, present, and future.
Topics: Animals; Antibiotics, Antineoplastic; Cardiomyopathies; Clinical Trials as Topic; Daunorubicin; Doxorubicin; Epirubicin; Female; Guinea Pigs; Heart; Humans; Idarubicin; Male; Menogaril; Mice; Nogalamycin; Rabbits; Rats | 1986 |
3 trial(s) available for daunorubicin and nogalamycin
Article | Year |
---|---|
Anthracycline analogs: the past, present, and future.
Topics: Animals; Antibiotics, Antineoplastic; Cardiomyopathies; Clinical Trials as Topic; Daunorubicin; Doxorubicin; Epirubicin; Female; Guinea Pigs; Heart; Humans; Idarubicin; Male; Menogaril; Mice; Nogalamycin; Rabbits; Rats | 1986 |
Phase II trial of menogaril in advanced colorectal cancer.
Topics: Adult; Aged; Antineoplastic Agents; Colorectal Neoplasms; Daunorubicin; Drug Administration Schedule; Drug Evaluation; Female; Hematologic Tests; Humans; Male; Menogaril; Middle Aged; Multicenter Studies as Topic; Neoplasm Metastasis; Nogalamycin | 1988 |
Menogaril: a new anthracycline agent entering clinical trials.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Clinical Trials as Topic; Cricetinae; Cricetulus; Daunorubicin; Dogs; Humans; Injections, Intravenous; Macaca mulatta; Menogaril; Mutagens; Neoplasms, Experimental; Nogalamycin; Rabbits; Rats; Rats, Inbred Strains | 1984 |
92 other study(ies) available for daunorubicin and nogalamycin
Article | Year |
---|---|
Differential fluorescent staining of human chromosomes with daunomycin and adriamycin--the d-bands.
Topics: Binding Sites; Chromosomes; Daunorubicin; Doxorubicin; Fluorescent Dyes; Humans; Male; Microscopy, Fluorescence; Nogalamycin; Staining and Labeling | 1975 |
Interaction of anthracyclines with DNA and chromosomes.
Topics: Animals; Chromatography, Gel; Chromosome Banding; Chromosomes; Daunorubicin; DNA; Mice; Naphthacenes; Nogalamycin; Quinacrine; Staining and Labeling | 1978 |
Selective inhibition of influenza virus protein synthesis by inhibitors of DNA function.
Topics: 4-Nitroquinoline-1-oxide; Camptothecin; Cell Line; Dactinomycin; Daunorubicin; Echinomycin; Ethidium; Hemagglutinins, Viral; Influenza A virus; Neuraminidase; Newcastle disease virus; Nogalamycin; Plicamycin; Proflavine; Viral Proteins; Virus Replication | 1977 |
Laser flow cytometry and cancer chemotherapy: detection of intracellular anthracyclines by flow cytometry.
Topics: Animals; Antibiotics, Antineoplastic; Carubicin; Cell Line; Cytological Techniques; Daunorubicin; DNA; Doxorubicin; Humans; Lasers; Leukemia; Mice; Nogalamycin; Propidium; Spectrometry, Fluorescence | 1979 |
Cellular pharmacology of 7(R)-O-methylnogarol: a new anticancer agent.
Topics: Animals; Cell Nucleus; Daunorubicin; Humans; In Vitro Techniques; Leukemia L1210; Leukemia, Experimental; Macromolecular Substances; Mice; Microscopy, Fluorescence; Naphthacenes; Neutrophils; Nogalamycin; Spectrometry, Fluorescence | 1979 |
Reductive microbial conversion of anthracycline antibiotics.
Topics: Aerobiosis; Aeromonas; Anthracyclines; Anti-Bacterial Agents; Citrobacter; Daunorubicin; Enterobacteriaceae; Escherichia coli; Glycosides; Kinetics; Naphthacenes; Nogalamycin; Oxidation-Reduction; Species Specificity | 1976 |
[Effects of various antibiotic agents on normal and cancerous cells].
Topics: Animals; Antibiotics, Antineoplastic; Carcinoma, Ehrlich Tumor; Cells, Cultured; Dactinomycin; Daunorubicin; Mice; Mitosis; Neoplasms; Nogalamycin | 1975 |
Microbial conversion of anthracycline antibiotics.
Topics: Aeromonas; Anthraquinones; Antibiotics, Antineoplastic; Bacteriological Techniques; Chemical Phenomena; Chemistry; Citrobacter; Daunorubicin; Escherichia coli; Nogalamycin | 1975 |
Inhibition of DNA helicase II unwinding and ATPase activities by DNA-interacting ligands. Kinetics and specificity.
Topics: Adenosine Triphosphatases; Daunorubicin; DNA; DNA Helicases; DNA, Single-Stranded; Escherichia coli; Escherichia coli Proteins; Intercalating Agents; Kinetics; Ligands; Mitoxantrone; Nogalamycin; Substrate Specificity | 1992 |
[Antitumor spectrum of TUT-7 on rat ascitic hepatoma].
Topics: Animals; Antineoplastic Agents; Daunorubicin; Drug Evaluation, Preclinical; Female; Liver Neoplasms, Experimental; Menogaril; Nogalamycin; Rats; Rats, Inbred Strains | 1990 |
[Antitumor activities of orally administered 7-con-0-methylnogarol (TUT-7)].
Topics: Administration, Oral; Animals; Antineoplastic Agents; Colonic Neoplasms; Daunorubicin; Doxorubicin; Humans; Leukemia L1210; Leukemia P388; Leukemia, Experimental; Lung Neoplasms; Menogaril; Mice; Nogalamycin; Rats; Sarcoma, Yoshida | 1990 |
Phase I study of oral menogaril administered on a once weekly schedule.
Topics: Administration, Oral; Adult; Antineoplastic Agents; Daunorubicin; Drug Administration Schedule; Drug Evaluation; Female; Hematologic Diseases; Humans; Male; Menogaril; Nogalamycin | 1990 |
Evaluation of menogaril in renal cell carcinoma. A Southwest Oncology Group phase II study (8504).
Topics: Antineoplastic Agents; Carcinoma, Renal Cell; Daunorubicin; Drug Evaluation; Humans; Kidney Neoplasms; Menogaril; Nogalamycin | 1990 |
Menogaril, an anthracycline compound with a novel mechanism of action: cellular pharmacology.
Topics: Animals; Antineoplastic Agents; Daunorubicin; DNA Damage; DNA, Neoplasm; Doxorubicin; Leukemia L1210; Menogaril; Microtubule Proteins; Neoplasm Proteins; Nogalamycin; Polyphosphates; RNA, Neoplasm; Tubulin | 1990 |
Role of oxygen free radical formation in the mechanism of menogaril resistance in multidrug resistant tumor cells.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Survival; Chemical Phenomena; Chemistry; Daunorubicin; DNA; Doxorubicin; Drug Resistance; Electron Spin Resonance Spectroscopy; Free Radicals; Humans; Menogaril; Nogalamycin; Oxygen; Tumor Cells, Cultured | 1990 |
Binding of the antitumor drug nogalamycin and its derivatives to DNA: structural comparison.
Topics: Base Composition; Base Sequence; Daunorubicin; DNA; Doxorubicin; Hydrogen Bonding; Intercalating Agents; Models, Molecular; Molecular Sequence Data; Nogalamycin; Nucleic Acid Conformation; Stereoisomerism; X-Ray Diffraction | 1990 |
Structure of nogalamycin bound to a DNA hexamer.
Topics: Base Sequence; Daunorubicin; DNA; Hydrogen Bonding; Models, Molecular; Molecular Sequence Data; Nogalamycin; Nucleic Acid Conformation; Oligodeoxyribonucleotides | 1990 |
Conformation and dynamics of the deoxyribose rings of a (nogalamycin)2-d (5'-GCATGC)2 complex studied in solution by 1H-n.m.r. spectroscopy.
Topics: Base Sequence; Chemical Phenomena; Chemistry, Physical; Daunorubicin; Intercalating Agents; Magnetic Resonance Spectroscopy; Molecular Structure; Nogalamycin; Nucleic Acid Conformation; Oligodeoxyribonucleotides; Solutions | 1990 |
NMR studies on the binding of antitumor drug nogalamycin to DNA hexamer d(CGTACG).
Topics: Base Sequence; Crystallization; Daunorubicin; DNA; Hydrogen Bonding; Hydrogen-Ion Concentration; Magnetic Resonance Spectroscopy; Molecular Conformation; Nogalamycin; Oligodeoxyribonucleotides; Solutions; Temperature | 1990 |
Footprinting reveals that nogalamycin and actinomycin shuffle between DNA binding sites.
Topics: Binding Sites; Dactinomycin; Daunorubicin; Deoxyribonuclease I; Distamycins; DNA; Echinomycin; Nogalamycin; Plicamycin; Temperature | 1986 |
Cytotoxic and mutagenic in vitro effect of 7-O-epoxyalkyl derivatives of daunomycinone. Part IX.
Topics: Animals; Carubicin; Cell Survival; Daunorubicin; DNA Replication; Leukemia P388; Mice; Mutagenicity Tests; Naphthacenes; Nogalamycin; RNA; Structure-Activity Relationship | 1986 |
Multidrug resistance in a human small cell lung cancer cell line selected in adriamycin.
Topics: Animals; Antibodies, Monoclonal; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Small Cell; Cell Line; Colchicine; Daunorubicin; Doxorubicin; Drug Resistance; Enzyme-Linked Immunosorbent Assay; Epirubicin; Etoposide; Glycoproteins; Gramicidin; Humans; Immunosorbent Techniques; Isoxazoles; Lung Neoplasms; Menogaril; Mice; Mice, Inbred BALB C; Mitoxantrone; Nogalamycin; Phenotype; Vinblastine; Vincristine | 1987 |
In vitro evaluation of the new anticancer agents KT6149, MX-2, SM5887, menogaril, and liblomycin using cisplatin- or adriamycin-resistant human cancer cell lines.
Topics: Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Agents; Bleomycin; Carubicin; Cisplatin; Daunorubicin; Doxorubicin; Drug Resistance; Humans; Menogaril; Mitomycins; Nogalamycin; Tumor Cells, Cultured | 1989 |
Phase II study of intravenous menogaril in advanced ovarian carcinoma. EORTC Early Clinical Trials Group.
Topics: Adult; Aged; Antineoplastic Agents; Daunorubicin; Drug Administration Schedule; Drug Evaluation; Female; Humans; Infusions, Intravenous; Menogaril; Middle Aged; Nogalamycin; Ovarian Neoplasms | 1989 |
Bidirectional transcription footprinting of DNA binding ligands.
Topics: Acridines; Base Sequence; Dactinomycin; Daunorubicin; Deoxyribonuclease I; Distamycins; DNA; Echinomycin; Escherichia coli; Genes, Bacterial; Ligands; Molecular Sequence Data; Nogalamycin; Nucleotide Mapping; Plicamycin; Promoter Regions, Genetic; Transcription, Genetic | 1989 |
Evaluation of menogaril in patients with metastatic sarcomas and no prior chemotherapy exposure.
Topics: Adult; Aged; Antineoplastic Agents; Daunorubicin; Drug Evaluation; Female; Humans; Leukopenia; Male; Menogaril; Middle Aged; Nogalamycin; Sarcoma | 1989 |
Pharmacokinetics and systemic bioavailability of menogaril, an anthracycline antitumor agent, in the mouse, dog, and monkey.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Biological Availability; Daunorubicin; Dogs; Female; Injections, Intravenous; Leukemia P388; Macaca mulatta; Menogaril; Mice; Mice, Inbred Strains; Nogalamycin; Species Specificity | 1989 |
Phase I study of weekly intravenous administration of menogaril to adults with solid tumors.
Topics: Adult; Aged; Agranulocytosis; Antineoplastic Agents; Daunorubicin; Dexamethasone; Drug Administration Schedule; Drug Evaluation; Female; Humans; Injections, Intravenous; Male; Menogaril; Middle Aged; Neoplasms; Nogalamycin; Prognosis; Thrombocytopenia | 1989 |
Antitumor drug nogalamycin binds DNA in both grooves simultaneously: molecular structure of nogalamycin-DNA complex.
Topics: Daunorubicin; DNA; Molecular Structure; Nogalamycin; Nucleic Acid Conformation | 1989 |
Negative phase II trial of menogaril in advanced squamous, adeno- and large cell carcinoma of the lung.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Daunorubicin; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Menogaril; Middle Aged; Nogalamycin | 1988 |
Evaluation of new anticancer agents against human pancreatic carcinomas in nude mice.
Topics: Adult; Aged; Alkaloids; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carcinoma, Intraductal, Noninfiltrating; Daunorubicin; Doxorubicin; Drug Evaluation; Epirubicin; Female; Humans; Male; Menogaril; Mice; Mice, Nude; Microtubules; Neoplasm Transplantation; Nogalamycin; Paclitaxel; Pancreatic Neoplasms; Random Allocation; Transplantation, Heterologous | 1987 |
Calmodulin inhibitor trifluoperazine selectively enhances cytotoxic effects of strong vs weak DNA binding antitumor drugs in doxorubicin-resistant P388 mouse leukemia cells.
Topics: Aminoacridines; Amsacrine; Animals; Anthraquinones; Antibiotics, Antineoplastic; Antineoplastic Agents; Cell Line; Dactinomycin; Daunorubicin; DNA; Doxorubicin; Drug Interactions; Drug Resistance; Leukemia P388; Leukemia, Experimental; Menogaril; Mice; Mitoxantrone; Naphthacenes; Nogalamycin; Trifluoperazine | 1985 |
Metabolism and disposition of menogaril (NSC 269148) in the rabbit.
Topics: Animals; Antineoplastic Agents; Bile; Daunorubicin; Fluorescence; Male; Menogaril; Metabolic Clearance Rate; Nogalamycin; Rabbits; Tissue Distribution | 1985 |
Synergistic combination of menogarol and melphalan and other two drug combinations.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Cell Survival; Cells, Cultured; Daunorubicin; Doxorubicin; Drug Synergism; Melanoma; Melphalan; Menogaril; Mice; Nogalamycin | 1985 |
Human pharmacokinetics, excretion, and metabolism of the anthracycline antibiotic menogaril (7-OMEN, NSC 269148) and their correlation with clinical toxicities.
Topics: Antineoplastic Agents; Bile; Biotransformation; Daunorubicin; Dose-Response Relationship, Drug; Humans; Kinetics; Leukocyte Count; Menogaril; Metabolic Clearance Rate; Neutrophils; Nogalamycin | 1986 |
Phase I clinical investigation of 7-con-O-methylnogaril, a new anthracycline antibiotic.
Topics: Antineoplastic Agents; Daunorubicin; Doxorubicin; Drug Evaluation; Hematopoiesis; Humans; Leukocyte Count; Menogaril; Neutrophils; Nogalamycin | 1986 |
In vitro activity of menogaril and N-demethylmenogaril in a human tumor cloning assay.
Topics: Breast Neoplasms; Cell Survival; Daunorubicin; Dose-Response Relationship, Drug; Female; Humans; Menogaril; Neoplastic Stem Cells; Nogalamycin; Ovarian Neoplasms; Tumor Stem Cell Assay | 1986 |
Human pharmacokinetics, excretion, and metabolism of the anthracycline antibiotic menogaril (7-OMEN, NSC 269148) and their correlation with clinical toxicities.
Topics: Daunorubicin; Humans; Menogaril; Models, Theoretical; Nogalamycin | 1986 |
Phase I trial of menogaril administered as an intermittent daily infusion for 5 days.
Topics: Adult; Aged; Antineoplastic Agents; Daunorubicin; Drug Administration Schedule; Drug Evaluation; Female; Hematologic Diseases; Humans; Infusions, Parenteral; Liver Neoplasms; Male; Menogaril; Middle Aged; Neoplasms; Nogalamycin | 1986 |
Effects of 7-R-O-methylnogarol (menogaril) on L1210 cell progression in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Cell Cycle; Cell Line; Daunorubicin; DNA, Neoplasm; Leukemia L1210; Male; Menogaril; Mice; Mice, Inbred Strains; Nogalamycin | 1986 |
Cross-resistance of menogaril and mitoxantrone in a subline of P388 leukemia resistant to doxorubicin.
Topics: Animals; Antineoplastic Agents; Body Weight; Cell Line; Daunorubicin; Doxorubicin; Drug Resistance; Leukemia P388; Life Expectancy; Menogaril; Mice; Mice, Inbred Strains; Mitoxantrone; Nogalamycin | 1987 |
A phase I study of menogaril in patients with advanced cancer.
Topics: Adult; Aged; Alopecia; Antineoplastic Agents; Daunorubicin; Doxorubicin; Drug Evaluation; Female; Follow-Up Studies; Hematologic Diseases; Humans; Kinetics; Male; Menogaril; Middle Aged; Nausea; Nogalamycin; Stroke Volume | 1987 |
Phase I and pharmacokinetic study of menogaril administered as a 72-hour continuous i.v. infusion.
Topics: Adult; Aged; Daunorubicin; Drug Evaluation; Female; Half-Life; Humans; Infusions, Intravenous; Kinetics; Male; Menogaril; Middle Aged; Neoplasms; Nogalamycin | 1987 |
Phase II trial of menogaril in patients with advanced colorectal carcinoma: an Illinois Cancer Council trial.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Colonic Neoplasms; Daunorubicin; Drug Evaluation; Female; Humans; Male; Menogaril; Middle Aged; Nogalamycin; Rectal Neoplasms | 1987 |
Pharmacokinetics of 7-con-O-methylnogarol in patients with solid tumors.
Topics: Aged; Daunorubicin; Female; Half-Life; Humans; Infusions, Intravenous; Kinetics; Male; Menogaril; Middle Aged; Neoplasms; Nogalamycin | 1987 |
Phase I study and pharmacokinetics of menogaril (NSC 269148) in patients with hepatic dysfunction.
Topics: Adult; Aged; Antineoplastic Agents; Daunorubicin; Drug Evaluation; Female; Humans; Liver; Liver Function Tests; Male; Menogaril; Middle Aged; Neoplasms; Nogalamycin | 1987 |
Phase II trial of menogaril in advanced malignant melanoma. An EORTC trial.
Topics: Adult; Aged; Antineoplastic Agents; Daunorubicin; Drug Evaluation; Female; Humans; Infusions, Intravenous; Male; Melanoma; Menogaril; Middle Aged; Nogalamycin; Skin Neoplasms | 1987 |
Phase II trial of menogarol in the treatment of advanced adenocarcinoma of the pancreas.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Daunorubicin; Drug Evaluation; Female; Humans; Male; Menogaril; Middle Aged; Nogalamycin; Pancreatic Neoplasms | 1988 |
Phase I clinical and pharmacokinetic trial of oral menogaril administered on three consecutive days.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Biological Availability; Daunorubicin; Drug Evaluation; Female; Half-Life; Humans; Leukopenia; Male; Menogaril; Middle Aged; Neoplasms; Nogalamycin | 1988 |
Phase II study of intravenous menogaril in patients with advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Daunorubicin; Drug Evaluation; Female; Humans; Infusions, Intravenous; Leukopenia; Menogaril; Middle Aged; Nogalamycin; Skin; Thrombocytopenia | 1988 |
Phase II evaluation of menogaril in women with metastatic breast cancer after failure of first-line chemotherapy.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Daunorubicin; Drug Administration Schedule; Drug Evaluation; Female; Humans; Menogaril; Neoplasm Metastasis; Nogalamycin | 1988 |
Phase I clinical trial of oral menogaril administered on three consecutive days.
Topics: Administration, Oral; Adult; Aged; Blood Cells; Daunorubicin; Drug Evaluation; Female; Heart; Humans; Liver; Male; Menogaril; Middle Aged; Neoplasms; Nogalamycin | 1988 |
Nucleotide sequence binding preferences of nogalamycin investigated by DNase I footprinting.
Topics: Anthracyclines; Anti-Bacterial Agents; Base Composition; Base Sequence; Daunorubicin; Deoxyribonuclease I; DNA; DNA Restriction Enzymes; Naphthacenes; Nogalamycin; Substrate Specificity | 1986 |
NMR studies of the interaction of the antibiotic nogalamycin with the hexadeoxyribonucleotide duplex d(5'-GCATGC)2.
Topics: Chemical Phenomena; Chemistry; Daunorubicin; Deoxyribonucleotides; Magnetic Resonance Spectroscopy; Nogalamycin | 1988 |
Footprinting studies on the interactions of nogalamycin, arugomycin, decilorubicin and viriplanin with DNA.
Topics: Anthracyclines; Antibiotics, Antineoplastic; Base Sequence; Daunorubicin; Deoxyribonuclease I; Diethyl Pyrocarbonate; DNA; Endodeoxyribonucleases; In Vitro Techniques; Molecular Sequence Data; Molecular Structure; Nogalamycin; Structure-Activity Relationship | 1988 |
Binding of nogalamycin to model tetranucleotides.
Topics: Calorimetry; Daunorubicin; Models, Molecular; Molecular Conformation; Nogalamycin; Nucleic Acid Conformation; Oligodeoxyribonucleotides | 1988 |
Kinetics of dissociation of nogalamycin from DNA: comparison with other anthracycline antibiotics.
Topics: Animals; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Binding Sites; Cattle; Daunorubicin; DNA; In Vitro Techniques; Kinetics; Naphthacenes; Nogalamycin; Poly dA-dT; Polydeoxyribonucleotides | 1985 |
Anthracycline antibiotic reduction by spinach ferredoxin-NADP+ reductase and ferredoxin.
Topics: Aclarubicin; Anti-Bacterial Agents; Daunorubicin; Ferredoxin-NADP Reductase; Ferredoxins; Manganese; NADH, NADPH Oxidoreductases; Naphthacenes; Nogalamycin; Plants; Stereoisomerism; Structure-Activity Relationship | 1985 |
Preferential binding of adriamycin and nogalamycin to DNase-I hypersensitive sites of Sarcoma-180 chromatin.
Topics: Animals; Binding Sites; Chromatin; Daunorubicin; Deoxyribonuclease I; DNA, Neoplasm; Doxorubicin; Mice; Nogalamycin; Sarcoma 180; Spectrometry, Fluorescence; Thermodynamics | 1986 |
DNA base sequence preference for adriamycin and nogalamycin binding.
Topics: Animals; Base Sequence; Cattle; Chemical Phenomena; Chemistry; Chromatin; Daunorubicin; DNA; Doxorubicin; Kinetics; Mice; Nogalamycin; Sarcoma 180; Structure-Activity Relationship; Thymus Gland | 1985 |
Comparative genotoxicity of adriamycin and menogarol, two anthracycline antitumor agents.
Topics: Animals; Antineoplastic Agents; Cell Line; Cell Nucleus; Cricetinae; Daunorubicin; Doxorubicin; Lung; Menogaril; Mesocricetus; Microsomes, Liver; Mutagenicity Tests; Mutagens; Mutation; Nogalamycin; Salmonella typhimurium; Structure-Activity Relationship | 1983 |
Quantitation of anthracycline antitumor agent menogarol in plasma using liquid chromatography with fluorescence detection.
Topics: Animals; Antibiotics, Antineoplastic; Chromatography, High Pressure Liquid; Daunorubicin; Dogs; Humans; Menogaril; Mice; Nogalamycin; Spectrometry, Fluorescence | 1984 |
Effect of antitumour drugs on protein synthesis.
Topics: Animals; Antineoplastic Agents; Daunorubicin; DNA, Neoplasm; Mice; Neoplasm Proteins; Nogalamycin; Plicamycin; Protein Biosynthesis; RNA, Neoplasm; Sarcoma 180 | 1980 |
Intracellular uptake of 7-con-o-methylnogarol and adriamycin by cells in culture and its relationship to cell survival.
Topics: Animals; Antibiotics, Antineoplastic; Biological Transport; Cell Cycle; Cell Nucleus; Cell Survival; Cells, Cultured; Cytoplasm; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Guinea Pigs; Menogaril; Mice; Nogalamycin | 1981 |
Inhibition of DNA-dependent RNA polymerase from sarcoma-180 ascites tumour cells by DNA-binding antitumor antibiotics.
Topics: Animals; Antibiotics, Antineoplastic; Daunorubicin; DNA-Directed RNA Polymerases; Male; Mice; Nogalamycin; Plicamycin; Sarcoma 180 | 1981 |
Effect of 7-con-O-methylnogarol on DNA synthesis, survival, and cell cycle progression of Chinese hamster ovary cells.
Topics: Animals; Antineoplastic Agents; Cell Cycle; Cell Survival; Cells, Cultured; Cricetinae; Cricetulus; Daunorubicin; DNA Replication; Female; Menogaril; Nogalamycin; Ovary; Time Factors | 1981 |
Rapid high-performance liquid chromatographic assay for the anthracyclines daunorubicin and 7-con-O-methylnogarol in plasma.
Topics: Antineoplastic Agents; Chromatography, High Pressure Liquid; Daunorubicin; Humans; Menogaril; Nogalamycin; Spectrometry, Fluorescence | 1981 |
Molecular models for the interaction of the anti-tumour drug nogalamycin with DNA.
Topics: Daunorubicin; DNA; Intercalating Agents; Models, Molecular; Nogalamycin; Nucleic Acid Conformation; Structure-Activity Relationship; Thermodynamics | 1984 |
Evidence of different binding sites for nogalamycin in DNA revealed by association kinetics.
Topics: Animals; Binding Sites; Cattle; Daunorubicin; DNA; Kinetics; Nogalamycin; Poly dA-dT; Polydeoxyribonucleotides | 1984 |
Interaction of nogalamycin with chromatin.
Topics: Chromatin; Chromosomal Proteins, Non-Histone; Daunorubicin; Drug Interactions; Nogalamycin; Protein Binding | 1983 |
Inhibition of alkaline ribonuclease activity by nogalamycin.
Topics: Animals; Daunorubicin; Liver; Mice; Nogalamycin; Pancreas; Ribonucleases | 1983 |
Laser flow cytometric studies on the intracellular fluorescence of anthracyclines.
Topics: Antibiotics, Antineoplastic; Carubicin; Cell Nucleus; Cells, Cultured; Cytoplasm; Daunorubicin; Doxorubicin; Glycosides; Humans; Lasers; Microscopy, Fluorescence; Naphthacenes; Nogalamycin; Spectrometry, Fluorescence | 1980 |
Structure--activity relationships of nogalamycin analogues.
Topics: Animals; Body Weight; Chemical Phenomena; Chemistry; Daunorubicin; Leukemia L1210; Leukemia P388; Mice; Nogalamycin; Structure-Activity Relationship | 1982 |
Template specificity of DNA binding by nogalamycin and its analogs utilizing competitive fluorescence polarization.
Topics: Acridine Orange; Animals; Base Composition; Binding, Competitive; Cattle; Circular Dichroism; Daunorubicin; DNA; DNA-Directed DNA Polymerase; Fluorescence Polarization; Methods; Nogalamycin; Nucleic Acid Denaturation; Templates, Genetic | 1981 |
Nogalamycin inhibits ribonucleic acid synthesis in growing and developing cells of the slime mold Dictyostelium discoideum.
Topics: Daunorubicin; Dictyostelium; Nogalamycin; RNA, Fungal; Time Factors | 1981 |
The interaction of nogalamycin and analogs with DNA and other biopolymers.
Topics: Animals; Cattle; Circular Dichroism; Daunorubicin; DNA; Hot Temperature; Leukemia L1210; Mice; Nogalamycin; Poly dA-dT; Polydeoxyribonucleotides; Spectrophotometry, Ultraviolet | 1981 |
Interactions of nogalamycin & ethidium bromide with chromatin & DNA - histone (f1) complex.
Topics: Chromatin; Daunorubicin; DNA; DNA, Neoplasm; Ethidium; Histones; Nogalamycin | 1980 |
Lethality of nogalamycin, nogalamycin analogs, and adriamycin to cells in different cell cycle phases.
Topics: Animals; Cell Division; Cell Survival; Cells, Cultured; Cricetinae; Cricetulus; Daunorubicin; DNA; Doxorubicin; Female; Interphase; Mitosis; Nogalamycin; Ovary; Time Factors | 1980 |
Cell kill kinetics of several nogalamycin analogs and adriamycin for Chinese hamster ovary, L1210 leukemia, and B16 melanoma cells in culture.
Topics: Animals; Cell Survival; Cells, Cultured; Cricetinae; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Female; Kinetics; Leukemia L1210; Melanoma; Mice; Neoplasms, Experimental; Nogalamycin; Ovary | 1981 |
Inhibition of DNA unwinding and ATPase activities of human DNA helicase II by chemotherapeutic agents.
Topics: Adenosine Triphosphatases; Amsacrine; Antineoplastic Agents; Aphidicolin; Camptothecin; Dactinomycin; Daunorubicin; DNA; DNA Helicases; Ellipticines; Enzyme Inhibitors; Ethidium; Etoposide; Genistein; Humans; Isoflavones; Nogalamycin; Novobiocin; Topoisomerase I Inhibitors | 1997 |
Characterization of Streptomyces nogalater genes encoding enzymes involved in glycosylation steps in nogalamycin biosynthesis.
Topics: Aclarubicin; Amino Acid Sequence; Cloning, Molecular; Daunorubicin; DNA, Bacterial; Genes, Bacterial; Genetic Complementation Test; Molecular Sequence Data; Nogalamycin; Open Reading Frames; Plasmids; Racemases and Epimerases; Restriction Mapping; Rhamnose; Sequence Alignment; Sequence Analysis, DNA; Streptomyces; UDPglucose 4-Epimerase | 1997 |
Inhibition of pea chloroplast DNA helicase unwinding and ATPase activities by DNA-interacting ligands.
Topics: Adenosine Triphosphatases; Adenosine Triphosphate; Amsacrine; Camptothecin; Chloroplasts; Dactinomycin; Daunorubicin; DNA Helicases; Ellipticines; Ethidium; Etoposide; Genistein; Hydrolysis; Intercalating Agents; Ligands; Nogalamycin; Novobiocin; Pisum sativum | 1998 |
Observation of daunomycin and nogalamycin complexes with duplex DNA using electrospray ionisation mass spectrometry.
Topics: Antibiotics, Antineoplastic; Binding, Competitive; Daunorubicin; DNA; Hydrogen-Ion Concentration; Indicators and Reagents; Mass Spectrometry; Nogalamycin; Oligonucleotides | 1999 |
Potent inhibition of DNA unwinding and ATPase activities of pea DNA helicase 45 by DNA-binding agents.
Topics: Adenosine Triphosphatases; Adenosine Triphosphate; Animals; Cell Nucleus; Chloroplasts; Cisplatin; Daunorubicin; DNA; DNA Helicases; Dose-Response Relationship, Drug; Ellipticines; Enzyme Inhibitors; Ethidium; Intercalating Agents; Nogalamycin; Nucleic Acid Synthesis Inhibitors; Pisum sativum; Plant Proteins; Rats | 2002 |
A novel nuclear DNA helicase with high specific activity from Pisum sativum catalytically translocates in the 3'-->5' direction.
Topics: Base Sequence; Cations, Divalent; Cell Nucleus; Dactinomycin; Daunorubicin; Dimerization; DNA Helicases; Ethidium; Kinetics; Molecular Weight; Nogalamycin; Pisum sativum; Plant Leaves; Substrate Specificity | 2003 |
The Gly-Arg-rich C-terminal domain of pea nucleolin is a DNA helicase that catalytically translocates in the 5'- to 3'-direction.
Topics: Adenosine Triphosphatases; Cloning, Molecular; Dactinomycin; Daunorubicin; DNA; DNA Helicases; DNA, Complementary; DNA, Single-Stranded; Dose-Response Relationship, Drug; Ethidium; Kinetics; Models, Genetic; Nogalamycin; Nucleolin; Phosphoproteins; Pisum sativum; Polymers; Protein Structure, Tertiary; Recombinant Proteins; RNA-Binding Proteins; Temperature; Ultraviolet Rays | 2005 |
Influence of initial charge state on fragmentation patterns for noncovalent drug/DNA duplex complexes.
Topics: Benzimidazoles; Daunorubicin; Distamycins; DNA; Indoles; Netropsin; Nogalamycin; Oligodeoxyribonucleotides; Pharmaceutical Preparations; Spectrometry, Mass, Electrospray Ionization | 2005 |
Complexation of anthracycline drugs with DNA in the presence of caffeine.
Topics: Anthracyclines; Anti-Bacterial Agents; Binding, Competitive; Buffers; Caffeine; Central Nervous System Stimulants; Daunorubicin; DNA; Doxorubicin; Drug Synergism; Magnetic Resonance Spectroscopy; Models, Chemical; Models, Statistical; Nogalamycin; Temperature | 2006 |
Inhibition of unwinding and ATPase activities of pea MCM6 DNA helicase by actinomycin and nogalamycin.
Topics: Adenosine Triphosphatases; Camptothecin; Cisplatin; Dactinomycin; Daunorubicin; DNA Helicases; Ellipticines; Enzyme Inhibitors; Etoposide; Intercalating Agents; Mitoxantrone; Nogalamycin; Novobiocin; Pisum sativum; Plant Proteins | 2011 |
Plasmodium falciparum UvrD activities are downregulated by DNA-interacting compounds and its dsRNA inhibits malaria parasite growth.
Topics: Antigens, Protozoan; Cells, Cultured; Daunorubicin; DNA Helicases; DNA, Protozoan; Ethidium; Etoposide; Humans; Malaria, Falciparum; Molecular Targeted Therapy; Netropsin; Nogalamycin; Plasmodium falciparum; RNA, Double-Stranded; RNA, Protozoan | 2014 |
Discriminating Intercalative Effects of Threading Intercalator Nogalamycin, from Classical Intercalator Daunomycin, Using Single Molecule Atomic Force Spectroscopy.
Topics: Daunorubicin; DNA; Intercalating Agents; Microscopy, Atomic Force; Molecular Structure; Nogalamycin; Spectrum Analysis | 2016 |
ATPase activity of Plasmodium falciparum MLH is inhibited by DNA-interacting ligands and dsRNAs of MLH along with UvrD curtail malaria parasite growth.
Topics: Adenosine Triphosphatases; Antimalarials; Daunorubicin; DNA Helicases; DNA Mismatch Repair; DNA, Protozoan; Drug Resistance; Ethidium; Etoposide; Malaria, Falciparum; Molecular Docking Simulation; MutL Protein Homolog 1; Netropsin; Nogalamycin; Plasmodium falciparum; RNA, Double-Stranded | 2017 |